Preview

Nephrology (Saint-Petersburg)

Advanced search

Arterial hypertension and survival in hemodialysis patients

Abstract

THE AIM: to evaluate blood pressure (BP) level importance measured in different phases of “dialysis” week as a prognostic factor in hemodialysis patients. PATIENTS AND METHOD: correlation between BP level before, during and after dialysis in in-terdialytic interval and survival of patients was estimated in two years prospective study of one dialysis center. RESULTS: BP in most of patients decreases during dialysis session and continues to decrease in interdialysis interval. BP before first session was 146±24 and 85±14, second - 141±19 and 82±13, third - 141±23 and 84±15 mm Hg, being in target range (<140/90 mm Hg) in 57% of women and 48% of men. The interdialysis body mass gain (BM) was linked only with systolic BP measured before session (r=0.222; p=0.04), and diastolic BP measured at any time point, more closely - with predialysis values (r=0.454÷0.281; p<0.01). Two year survival (Kaplan-Meier) was not associated with predialysis and intradialysis BP; the association with postdialysis BP was close to significance in adjusted Cox regression model (p=0.051). Interdialysis BP higher 141 mm Hg (border of upper and middle tercile) was interrelated with mortality relative risk (RR) 3.23 (95%CI 1.08÷9.66); p=0.036. Regression model also included BM gain (RR=1.73 per 1% IWG), age (RR +7% per 1 year) and gender. Diastolic BP higher than 84 mm HG in interdialysis period was associated with increase of mortality level: RR=6.84 (95%CI 1.55÷30.2) p=0.011. CONCLUSION: BP in interdialysis period is significantly more important for survival than on dialysis.

About the Authors

A. B. Sabodash
First nephrology and dialysis Saint-Petersburg State medical university n.a. I.P Pavlov; BBraun Avitum Russland Clinics
Russian Federation


N. S. Kazantseva
BBraun Avitum Russland Clinics
Russian Federation


A. Y. Zemchenkov
First nephrology and dialysis Saint-Petersburg State medical university n.a. I.P Pavlov; North-Western State medical university n.a. I.I.Mechnikov
Russian Federation


K. A. Salikhova
BBraun Avitum Russland Clinics
Russian Federation


O. V. Makarova
BBraun Avitum Russland Clinics
Russian Federation


G. A. Zemchenkov
BBraun Avitum Russland Clinics
Russian Federation


V. V. Skaternikova
BBraun Avitum Russland Clinics
Russian Federation


A. V. Banishevskaya
BBraun Avitum Russland Clinics
Russian Federation


References

1. Ермоленко ВМ, Филатова НН. О целевых значениях артериального давления у больных ХБП (обзор литературы). Нефрология и диализ 2010; 12(4): 238-241 [Ermolenko VM, Filatova NN. On the target blood pressure in patients with CKD; Review. Nephrology and Dialysis (in Rus) 2010; 12(4): 238-241]

2. KDIGO Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int 2012; 2(Suppl.): 337-414

3. Taler SJ, Agarwal R, Bakris GL et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis 2013; 62(2): 201-213

4. Verbeke F, Lindley E, Van Bortel L et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant 2014; 29(3): 490-496

5. Roberts MA. Commentary on the KDIGO Clinical Practice Guideline for the management of blood pressure in chronic kidney disease. Nephrology (Carlton) 2014; 19(1): 53-55

6. Akbari A, Clase CM, Acott P et al. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management. Am J Kidney Dis 2015; 65(2): 177-205

7. Gorostidi M, Santamarfa R, Alcâzar R et al. Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease. Nefrologia 2014; 34(3): 302-316

8. Кутырина ИМ, Швецов МЮ, Фомин ВВ и др. Диагностика и лечение артериальной гипертензии при хронической болезни почек. Национальные рекомендации Научного общества нефрологов России и Ассоциации нефрологов. Клиническая нефрология 2015; 4: 4-29 [Kutyrina IM, Shvetcov MIu, Fomin VV i dr. Diagnosis and treatment of arterial hypertension in chronic kidney disease. Clinicheskaia nefrologiia (in Rus) 2015; 4: 4-29]

9. Zoccali C, Tripepi R, Torino C et al. Moderator’s view: Ambulatory blood pressure monitoring and home blood pressure for the prognosis, diagnosis and treatment of hypertension in dialysis patients. Nephrol Dial Transplant 2015; 30(9): 1443-1448

10. Agarwal R. Treating hypertension in hemodialysis improves symptoms seemingly unrelated to volume excess. Nephrol Dial Transplant 2015 Nov 5. pii: gfv371. [Epub ahead of print]

11. Herrington W, Haynes R, Staplin N et al. Evidence for the prevention and treatment of stroke in dialysis patients. Semin Dial 2015; 28(1): 35-47

12. Heerspink HJ, Ninomiya T, Zoungas S et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet 2009; 373 (9668): 1009-1015

13. Agarwal R, Peixoto AJ, Santos SF et al. Out-of-office blood pressure monitoring in chronic kidney disease. Blood Press Monit 2009; 14(1): 2-11

14. Li Z, Lacson E Jr, Lowrie EG et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 2006; 48(4): 606-615

15. Myers OB, Adams C, Rohrscheib MR et al. Age, race, diabetes, blood pressure, and mortality among hemodialysis patients. J Am Soc Nephrol 2010; 21(11): 1970-1978

16. Agarwal R, Alborzi P, Satyan S, Light RP Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009; 53(3): 500-507

17. Huang SH, Filler G, Lindsay R, McIntyre CW. Euvolemia in hemodialysis patients: a potentially dangerous goal? Semin Dial 2015; 28(1): 1-5

18. Kotanko P, Garg AX, Depner Tet al. Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials. Hemodial Int 2015; 19(3): 386-401

19. Arramreddy R, Sun SJ, Munoz Mendoza J et al. Individualized reduction in dialysate sodium in conventional in-center hemodialysis. Hemodial Int 2012; 16(4): 473-480

20. Sinha AD, Agarwal R. Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status. Semin Dial 2009; 22(5): 480-482

21. Вишневский КА, Герасимчук РП, Земченков АЮ. Коррекция «сухого веса» у больных, получающих лечение программным гемодиализом, по результатам векторного анализа биоимпеданса. Нефрология 2014; 18(2): 61-71. [Vishnevskii KA, Gerasimchuk RP, Zemchenkov AYu. «Dry weight » correction in hemodialysis patients based on the results of bioimpedance vector analysis. Nephrology (in Rus) 2014; 18(2): 61-71]

22. Sânchez-Perales C, Vazquez E, Garcfa-Cortés MJ et al. Ischaemic stroke in incident dialysis patients. Nephrol Dial Transplant 2010; 25(10): 3343-3348

23. Seliger SL, Gillen DL, Tirschwell D et al. Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 2003; 14(10): 2623-2631

24. Добронравов ВА, Боровская ЕА, Владимирова ЮФ, Смирнов АВ. Динамика артериального давления и его суточного профиля у пациентов на стандартном программном гемодиализе: данные двухсуточного мониторирования. Нефрология 2009; 13(2): 42-49. [Dobronravov VA, Borovskaya EA, Vladimirova UF, Smirnov AV. The dynamics of the blood pressure and its daily profile in patients with standard program haemodi-alysis: the data from 48 hours monitoring. Nephrology (in Rus) 2009; 13(2): 42-49]

25. Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension 2010; 55(3): 762-768

26. Ляшенко ОА, Гуревич КЯ, Корнеев АМ. Клинические, лабораторные и инструментальные характеристики, ассоциированные с артериальной гипертензией у больных, находящихся на программном гемодиализе. Нефрология 2011; 15(2): 49-56. [Lyashenko OA, Gurevich KYa, Korneev AM. Clinical, laboratory and istrumental parameters associated with arterial pressure at patients’ on programmed hemodialysis. Nephrology (in Rus) 2011; 15(2): 49-56]

27. Бовкун ИВ, Румянцев АШ. Состояние жидкостных пространств организма у пациентов с хронической болезнью почек, получающих лечение программным гемодиализом. Нефрология 2012 16(3): 98-105

28. Бикбов БТ, Томилина НА. Факторы риска смерти больных, впервые начинающих лечение гемодиализом (по данным Регистра Российского диализного общества). Нефрология и диализ 2008; 10(1): 35-43. [Bikbov BT, Tomilina NA. Predictors of mortality among incident hemodialysis patients: a cohort study (data of Russian Registry of Renal Replacement Therapy). Nephrology and dialysis 2008; 10(1): 35-43]

29. Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 1998; 32 (5): 720-724

30. Добронравов ВА, Владимирова ЮФ, Боровская ЕА и соавт. Ишемия миокарда у больных на программном гемодиализе: результаты 7-летнего проспективного обсервационного исследования. Нефрология 2013; 17(1): 49-59. [Dobronravov VA, Vladimirova YuF, Borovskaya EA et al. Myocardial ischemia in patients on maintenance haemodialysis: results of 7-year prospective observational study. Nephrology (in Rus) 2013; 17(1): 49-59]

31. Добронравов ВА, Смирнов АВ, Владимирова ЮФ, Боровская ЕА. Связь между развитием эпизодов ишемии миокарда и изменениями артериального давления у больных с ИБС, получающих лечение хроническим гемодиализом. Нефрология 2008; 12(3): 24-35. [Dobronravov VA, Smirnov AV, Vladimirova UF, Borovskaya EA. The connection between the development of ischemic myocardial episodes and the changes of blood pressure in chronic hemodialysis patients with CHD. Nephrology (in Rus) 2008; 12(3): 24-35]

32. Ogura M, Yamada Y, Terawaki H et al. Home systolic blood pressure on the morning of dialysis days has prognostic impact for hypertensive hemodialysis patients. Clin Exp Nephrol 2012; 16(3): 427-32

33. Yang CY, Yang WC, Lin YP. Postdialysis blood pressure rise predicts long-term outcomes in chronic hemodialysis patients: a four-year prospective observational cohort study. BMC Nephrol 2012; 13: 12

34. Шило ВЮ, Земченков АЮ, Гуревич КЯ и др. Лечение анемии при хронической почечной недостаточности. В кн. Клинические рекомендации. Нефрология. Геотар 2016; 568-589. [Shilo VYu, Zemchenkov AYu, Gurevich KYa i dr. Lechenie anemii pri khronicheskoi pochechnoi nedostatochnosti. In: Clinicheskie rekomendatcii. Nefrologiia (in Rus). Geotar 2016; 568-589]

35. Bansal N, McCulloch CE, Rahman M et al. Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study. Hypertension 2015; 65(1): 93-100

36. Da Silva GV, De Barros S, Abensur H et al. Home blood pressure monitoring in blood pressure control among haemo-dialysis patients: an open randomized clinical trial. Nephrol Dial Transplant 2009; 24(12): 3805-3811

37. Park J, Rhee CM, Sim JJ et al. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int 2013; 84(4): 795-802


Review

For citations:


Sabodash A.B., Kazantseva N.S., Zemchenkov A.Y., Salikhova K.A., Makarova O.V., Zemchenkov G.A., Skaternikova V.V., Banishevskaya A.V. Arterial hypertension and survival in hemodialysis patients. Nephrology (Saint-Petersburg). 2016;20(4):62-71. (In Russ.)

Views: 1244


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)